Precision Peptide Company orders 20,000 thymosin alpha-1 patches for launch
The order covers a transdermal patch format for the immune peptide ahead of what the company describes as its commercial launch.
TR
By Tom Reyes · Markets Editor
Oct 7 13:38 ETSource: Yahoo Finance
The wire
- 01The Precision Peptide Company says it has ordered 20,000 thymosin alpha-1 patches to supply a commercial launch.
- 02Thymosin alpha-1 is tracked closely by clinicians and compounders given ongoing uncertainty about its regulatory standing in the US.
- 03The announcement is a company statement; launch timing, pricing, markets served and any clinical data supporting the patch are not detailed.
From the source
Read at finance.yahoo.comThe Precision Peptide Company Orders 20,000 Thymosin Alpha-1 Patches for Commercial Launch
